Our current research projects

As an established and respected provider of excellence in palliative care, Sue Ryder is well placed to adopt a key position in the national research community, supporting and influencing the development of palliative research, and its translation into improved clinical practice. Sue Ryder has engaged in important clinical research for many years. Studies have ranged from small-scale academic projects by Masters students to national commercial clinical drug trials.

Within Sue Ryder, we are working together to nurture an inclusive research culture. Our goal is to foster curiosity, and turn this curiosity into innovative and progressive practice by engaging our staff, volunteers, service users, their families and carers in research and making participation the norm.

Research at Sue Ryder is supported and governed by a dedicated Research Governance Group (RGG). The RGG meets quarterly to discuss, review and approve existing and potential research projects, and to produce, develop and maintain robust research governance documents, polices, strategies and processes.

Our Research Lead acts as a first point of contact for research within and without the organisation and coordinates and develops research within Sue Ryder.

Research plays an essential role in the discovery and implementation of the best possible, evidence-based care for our own patients and service users, and for those in the wider palliative environments.

Through research we review and challenge current practice, and continue to ask the vital question "Are we doing the best we can?"

The discoveries that are made through research lead to advances and improvements in treatments, therapies and approaches to care.

Our Chief Medical Officer, Dr Paul Perkins, is the lead for research at Sue Ryder.